Literature DB >> 28662925

The best in vitro conditions for two and three parallel stenting during endovascular aneurysm repair.

Gaspar Mestres1, Xavier Yugueros2, Ana Apodaka3, Rodrigo Urrea2, Savino Pasquadibisceglie2, Xavier Alomar4, Vincent Riambau2.   

Abstract

OBJECTIVE: The aim of this study is to identify which endograft-parallel stent combinations and which degree of oversizing result in the most adequate fit in a juxtarenal abdominal aneurysmal neck, when using a double or triple parallel-stent (chimney) technique.
METHODS: In vitro silicon, juxtarenal, abdominal aortic aneurysmal neck models of different diameters, with two and three side-branches (simulating both the renal and superior mesenteric arteries), were constructed. Two different endografts of three diameters each, with two or three parallel stents (of 6 mm and 6 mm; or 6 mm, 6 mm, and 8 mm) were tested (Endurant-II endograft [Medtronic Inc, Santa Rosa, Calif] with balloon-expandable BeGraft stent [Bentley InnoMed, Hechingen, Germany] and an Excluder endograft [W. L. Gore and Associates, Flagstaff, Ariz] with self-expanding Viabahn stent [W. L. Gore and Associates]), applying three endograft-oversizing degrees: recommended (15%), excessive (30%), and over-excessive (40%). After remodeling, using the kissing-balloon technique at 37°C (98.6°F), 36 endograft-stent-oversizing models were scanned by computed tomography. The area of the gutters, parallel-stent compression, and main endograft infolding were recorded.
RESULTS: Increasing oversizing (15%, 30%, and 40%) revealed a nonsignificant propensity toward smaller gutters and similar parallel-stent compression, but it significantly augmented infolding, more in three parallel-stent models (0%, 0%, 67% and 0%, 33%, 83% of cases; P = .015 and .018, for two and three parallel-stent models; n = 36) and mainly for the Excluder-Viabahn combination. The Excluder-Viabahn showed significantly smaller gutters, but with higher stent compression, than Endurant-BeGraft combinations for both two and three parallel stents (8.2 mm2, 22.6 mm2; P = .002 and 14.4 mm2, 23.3 mm2; P = .009 gutter area; and 18%, 2%; P < .001 and 15%, 2%; P = .007 relative stent area compression, respectively).
CONCLUSIONS: Better endograft stent apposition was usually attained when using 30% oversizing during two and three parallel-stent techniques. Higher oversizing was related to nonsignificant smaller gutters but higher rates of infolding. Smaller gutters, but higher stent compression and risk of infolding, were achieved with the Excluder-Viabahn than with the Endurant-BeGraft combination.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28662925     DOI: 10.1016/j.jvs.2016.09.046

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Deployment of stent graft in an excessively higher position above the renal artery induces a flow channel to the aneurysm in chimney endovascular aortic aneurysm repair: an in vitro study.

Authors:  Kota Shukuzawa; Taku Akaoka; Mitsuo Umezu; Takao Ohki; Kiyotaka Iwasaki
Journal:  J Artif Organs       Date:  2019-01-20       Impact factor: 1.731

2.  Endovascular Aortic Arch Reconstruction with Parallel Grafts: A Dilemma of Excessive Endograft Oversizing.

Authors:  Huey-Shiuan Kuo; Kun-Cheng Tsai; Jer-Shen Chen
Journal:  Acta Cardiol Sin       Date:  2020-07       Impact factor: 2.672

3.  Off the Shelf Thoracic Endovascular Aortic Repair with Sandwich Technique for the Treatment of a Thoraco-Abdominal Penetrating Aortic Ulcer.

Authors:  Tiago F Ribeiro; Nelson Camacho; Rita S Ferreira; Frederico Bastos Gonçalves; Maria Emília Ferreira
Journal:  EJVES Vasc Forum       Date:  2022-04-22

4.  Clinical Validation of the Impact of Branch Stent Extension on Hemodynamics in ISF-TEVAR Involving LSA Reconstruction.

Authors:  Jiateng Hu; Fengshi Li; Peng Qiu; Xiaoyu Wu; Hongji Pu; Zhen Zhao; Jinbao Qin; Guang Liu; Shanliang Jin; Xinwu Lu; Xiaobing Liu
Journal:  Front Cardiovasc Med       Date:  2022-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.